Progyny Inc
NASDAQ:PGNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Progyny Inc
NASDAQ:PGNY
|
US |
|
D
|
Dermapharm Holding SE
XMUN:DMP
|
DE |
|
Liberty Global PLC
NASDAQ:LBTYA
|
UK |
|
DCI Indonesia Tbk PT
IDX:DCII
|
ID |
|
S
|
Sasol Ltd
JSE:SOL
|
ZA |
Wall St Price Targets
PGNY Price Targets Summary
Progyny Inc
According to Wall Street analysts, the average 1-year price target for
PGNY is 30.6 USD with a low forecast of 26.26 USD and a high forecast of 34.65 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PGNY's stock price target?
Price Target
30.6
USD
According to Wall Street analysts, the average 1-year price target for
PGNY is 30.6 USD with a low forecast of 26.26 USD and a high forecast of 34.65 USD.
What is the Revenue forecast for Progyny Inc?
Projected CAGR
6%
Over the last 7 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 7 years is 6%.
What is the Gross Profit forecast for Progyny Inc?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 48%. The projected CAGR for the next 7 years is 8%.
What is the Operating Income forecast for Progyny Inc?
Projected CAGR
21%
The compound annual growth rate for Operating Income over the next 7 years is 21%.
What is the Pre-Tax Income forecast for Progyny Inc?
Projected CAGR
35%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 35%.
What is the Net Income forecast for Progyny Inc?
Projected CAGR
23%
The compound annual growth rate for Net Income over the next 7 years is 23%.